PE/Cyanine5.5 Anti-Human CD19 Antibody[4G7]

Introducing the PE/Cyanine5.5 Anti-Human CD19 Antibody [4G7], a highly advanced and meticulously developed product designed to revolutionize the field of immunology. This antibody, meticulously engineered using cutting-edge technology, offers unparalleled specificity and sensitivity in detecting the CD19 antigen on human cells.

The PE/Cyanine5.5 Anti-Human CD19 Antibody [4G7] is a powerful tool for researchers and clinicians alike, enabling precise identification and characterization of CD19-positive cells in various biological samples. Its exceptional performance is attributed to the fusion of the PE fluorochrome and Cyanine5.5 dye, resulting in a robust and reliable signal amplification system.

This antibody exhibits exceptional binding affinity and selectivity towards the CD19 antigen, ensuring accurate and reproducible results. Its high specificity minimizes the risk of cross-reactivity, guaranteeing reliable and precise data interpretation. Moreover, the PE/Cyanine5.5 conjugate provides enhanced stability and brightness, facilitating effortless detection and analysis.

The PE/Cyanine5.5 Anti-Human CD19 Antibody [4G7] is meticulously manufactured under stringent quality control measures, ensuring consistent and reliable performance across multiple experiments. Its exceptional purity and low background noise contribute to the generation of high-quality data, enabling researchers to draw meaningful conclusions and advance their scientific endeavors.

This product is compatible with a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility allows for seamless integration into various experimental protocols, providing researchers with the flexibility they need to explore the intricacies of CD19 biology.

In summary, the PE/Cyanine5.5 Anti-Human CD19 Antibody [4G7] represents a breakthrough in immunological research, offering unmatched sensitivity, specificity, and reliability. With its exceptional performance and compatibility with various applications, this antibody is poised to revolutionize the study of CD19-positive cells and contribute to advancements in the field of immunology.